Skip to main content

Table 1 Comparison of general characteristics of HIV-infected patients on HAART with and without insulin resistance (IR)

From: Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional study

General characteristics (n = 219)

Total (n = 219)

No IR (n = 144)

IR (n = 75)

PR

P

Male, n (%)

147 (67.1)

96 (66.7)

51 (68.0)

1.041

0.844

Age

    

0.007

   ≤ 35 years, n (%)

95 (43.4)

70 (48.6)

25 (33.3)

1.000

Reference

  36-45 years, n (%)

74 (33.8)

50 (34.7)

24 (32.0)

1.232

0.398

   ≥ 46 years, n (%)

50 (22.8)

24 (16.7)

26 (34.7)

1.976

0.002

Hispanics, n (%)

190 (86.7)

124 (86.1)

66 (88.0)

1.119

0.709

Family history of T2DM, n (%)

51 (23.3)

34 (23.6)

17 (22.7)

0.965

0.877

Cigarrette smoker, n (%)

54 (24.7)

40 (27.8)

14 (18.7)

0.701

0.186

>1 year on HAART, n (%)

167 (76.3)

106 (73.6)

61 (81.3)

1.357

0.249

HAART regimen with PI, n (%)

20 (9.1)

11 (7.6)

9 (12.0)

1.357

0.235

  1. Abbreviations: HAART highly active antiretroviral therapy; IR insulin resistance; PR prevalence ratio; PI protease inhibitor; T2DM type 2 diabetes mellitus